Insider Transactions in Q2 2018 at Homology Medicines, Inc. (FIXX)
Insider Transaction List (Q2 2018)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 02
2018
|
Temasek Holdings (Private) LTD > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
625,000
+16.25%
|
$10,000,000
$16.0 P/Share
|
|
Apr 02
2018
|
Temasek Holdings (Private) LTD > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
2,595,293
+38.8%
|
-
|
|
Apr 02
2018
|
James E Flynn > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
1,250,000
+34.65%
|
$20,000,000
$16.0 P/Share
|
|
Apr 02
2018
|
James E Flynn > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
3,977,035
+44.94%
|
-
|
|
Apr 02
2018
|
Rock Springs Capital Management LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
250,000
+27.91%
|
$4,000,000
$16.0 P/Share
|
|
Apr 02
2018
|
Rock Springs Capital Management LP > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
395,845
+50.0%
|
-
|
|
Apr 02
2018
|
Novartis Institutes For Bio Medical Research, Inc. > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
1,979,226
+50.0%
|
-
|